Active Implants Management Team

Harris joined the Active Implants team in 2017, bringing 25 years of leadership and experiences in market access, health economics and reimbursement for the U.S. and international markets. Prior to this role, he served as senior director of global reimbursement and market access at Wright Medical Technology, Inc., a global medical device company focused on extremities and biologics; senior director of reimbursement and global market access for Biomimetic Therapeutics, LLC., a biotechnology company that develops products for the healing of musculoskeletal injuries and disease (acquired by Wright Medical in 2013); and manager of market access and reimbursement at Zimmer, Inc. (now Zimmer Biomet), a global musculoskeletal medical device company. Through multiple roles at health care organizations and medical device companies, he brings to Active Implants extensive experience in legislative and government affairs, health care finance, health care policy analysis, advocacy and lobbying, and provider/pay.

Keenan has served as chief financial officer since 2009. Keenan has extensive experience in the financial leadership for privately held startups and growth-stage companies. Prior to Active Implants, Keenan led the finance efforts at a successful telecommunications private equity firm. He has also held positions with an international accounting and consulting firm, where he consulted with businesses ranging from small, local operations to Fortune 500 companies on issues such as financial systems design, internal controls implementation, debt and equity financing, and corporate income tax strategy. As a valuation, merger and acquisition consultant, he assisted clients in analyzing strategic investments and divestitures, performed forecast modeling, provided valuation opinions for estate, gift, and income tax planning, assisted in pre-IPO planning, and negotiated the purchase and sale of businesses and business operations. Keenan is a Certified Public Accountant (CPA) and holds the Chartered Financial Analyst (CFA) designation.

Klyce brings over 20 years of experience in the medical technology field. Prior to joining Active Implants in 2015, he served in a consulting role, spearheading patient recruitment and development of clinical trial investigational sites for the NUsurface® Meniscus Implant. Prior to this, he held roles as vice president of marketing at Spartek Medical, Inc., a developer of spinal implants, and director of marketing at St. Francis Medical Technologies, a privately held company that developed and marketed the X STOP Interspinous Process Decompression System. Klyce played a primary role in the successful acquisition of St. Francis by Kyphon Inc. in January 2007. Kyphon was later acquired by Medtronic (NYSE: MDT). He received his bachelor of arts in public relations from Humboldt State University.

Eric Meeder has over 15 years of leadership and experience in financial roles within the medical technology field. Meeder joined Active Implants in 2012. Prior to Active Implants, Meeder led as Controller and Operations Manager the European financial and operational efforts at Pioneer Surgical. Prior to this, he held roles as Controller for St. Francis Medical Technologies and MedLink Europe.

Dr. Linder-Ganz joined Active Implants in 2006. In addition to serving as vice president of research & development, Dr. Linder-Ganz is managing director of Active Implants Israel and was involved in the development of the NUsurface® Meniscus Implant from the very first sketch. He received his doctorate in biomedical engineering at Tel-Aviv University. His seven years research into injury mechanics focused on the pathomechanics of deep tissue injury (DTI, pressure ulcers). In his research, he developed his expertise in experimental and computational aspects of musculoskeletal biomechanics. One of the major topics was an integration of computational, experimental and imaging approaches in a clinical study examining the risk of developing pressure ulcers among wheelchair users. He published a collection of peer-reviewed journal articles as well as more than 100 conference abstracts, three book chapters and granted four U.S. patents.

Ryan is an orthopedic Biomedical Engineer, Regulatory, Clinical, and Quality Leader with over 16 years of diverse medical device experience. His expertise includes an established rapport with FDA and CMS via clinical, regulatory, reimbursement, quality assurance interactions and full cycle product development. Ryan joined Active Implants as Director of Regulatory in 2017 and moved into his current role as Vice President, Clinical & Regulatory Affairs in 2020. Previously, Ryan was Director, Applied Research with RTI Surgical and Sr. Director, Regulatory Affairs and Quality Assurance at AgNovos Healthcare.

Dr. Treharne has been in his current role since 2006. Dr. Treharne was previously employed as vice president of regulatory affairs at Medtronic Sofamor Danek, now Medtronic Spine and Biologics. He received his undergraduate engineering degree from The Ohio State University, master’s and doctorate degrees from the University of Pennsylvania, and a master’s of business administration from the University of Memphis.